Frequently Asked Questions

Frequently Asked

Who can participate in this research study?

This research study is evaluating an investigational medication when used with standard-of-care medication for adults with active IIM. You may be able to take part in this study if you:

Are at least 18 years of age
Have active IIM confirmed by a physician (such as a rheumatologist, neurologist, or dermatologist)
Are taking standard-of-care medication to treat your active IIM
Meet at least 1 of the following criteria at screening:

  • Have an active rash associated with IIM
  • Have a muscle biopsy, muscle MRI, or electromyography report from the past 12 weeks that confirms active IIM
  • Have any muscle enzyme elevation (this will be tested during the screening period)
What’s involved with study participation?

This study will evaluate the safety and efficacy of an investigational medication (a medication not approved for clinical use) when used with standard-of-care medications for adults with active IIM.

The study will involve study visits every 2 weeks over the course of up to 112 weeks, or about 26 months. About 200 participants will be enrolled, and they may be compensated for study-required travel and expenses.

How long is this research study?

If eligible, participation can last about 26 months.

What is the medication being tested?

The investigational medication in this study is a liquid solution administered via IV infusion (through a vein).

What about my current medications?

Do not discontinue any medication unless you are advised to do so by the study center staff or your primary care physician.

Does participating in this study cost me anything?

There is no cost to you for participating in the study.

Why did I disqualify?

Clinical research studies are designed in specific ways, and one or more of the answers that you provided were outside of the guidelines for this study. This does not mean you will not qualify for different research studies.